Risk of developing cancer increased by prediabetes
the ONA take:
According to a new meta-analysis published in the journal Diabetologia, the journal of the European Association for the Study of Diabetes, the risk of developing cancer is increased by prediabetes. That risk differs depending on the type of cancer. In the study, researchers evaluated 16 studies from Asia, the United States, Europe, and Africa.
The researchers found that prediabetes is linked with a 15% elevated risk of developing cancer overall. They found that the results were similar across age, cancer endpoint, duration of follow-up, and ethnicity. In addition, acknowledging that obesity is also linked to the development of cancer, researchers performed a sensitivity analysis that adjusted for body mass index and found that prediabetes was linked with a 22% increased risk of cancer.
When analyzing specific cancers, researchers found that prediabetes was associated with an increased risk of breast, colorectum, endometrium, liver, pancreas, and stomach cancer, but not linked with bladder, kidney, lung, ovary, or prostate cancer.
Prediabetes refers to a hemoglobin A1C (Hgb A1C) between 5.7% and 6.4%, with diabetes beginning when a patient has a Hgb A1C of 6.5% or higher.
That risk differs depending on the type of cancer.
A meta-analysis comprising 16 studies and 891,426 participants from various regions of the world shows that prediabetes increases the risk of cancer by 15%, with differing risks depending on the type of cancer. The study, published in Diabetologia (the journal of the European Association for the Study of Diabetes) is by Professor Yuli Huang, The First People's Hospital of Shunde, Daliang Town, Shunde District, China, and colleagues.
Prediabetes is a general term that refers to an intermediate stage between normoglycaemia and overt diabetes mellitus. It includes individuals with impaired glucose tolerance (IGT), impaired fasting glucose (IFG) or a combination of the two. Results to date from prospective cohort studies investigating the link between prediabetes and risk of cancer are controversial.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- No Difference Between RA Seed Localization and Wire Guided Localization
- BRD4 Inhibitor May Enhance Sensitivity to Endocrine Therapies
- Dual HER2 Blockade With an AI Effective in Advanced Breast Cancer
- Loperamide Regimen May Reduce Diarrhea in Neratinib-treated Patients
- PAM50 HER2-E Subtype Predicts pCR Following Lapatinib, Trastuzumab
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|